The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Investing in health systems to protect society and boost the economy: Priority investments and order-of-magnitude cost estimates
Abstract
COVID-19 is the most significant public health emergency in more than a century, causing a global economic crisis, and with long-term repercussions across society. COVID-19 continues to claim lives, many are suffering ill health (physical and/or mental) due to the virus, and health systems struggle to recover from the massive disruption. This unprecedented crisis has highlighted the urgent need for smart investments to strengthen health system resilience – to protect people’s underlying health, through enhanced preventive care and the ability to reinforce defences in acute times, to fortify the foundations of health systems by ensuring adequate core equipment and exploiting the potential of health information, and to bolster health professionals working on the frontline by building and maintaining sufficient numbers of doctors and nurses – thereby providing countries with the agility to respond not only to evolving pandemics but also to other health and societal shocks. This report identifies a set of priority investment areas needed to strengthen health system resilience. It then produces order-of-magnitude estimates of the expected costs of such investments, drawing extensively from existing OECD data and analytical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tackling Wasteful Spending on Health
OECD (2017) · OECD eBooks · doi:10.1787/9789264266414-en · Cited by 1,448
WHO Report on the Global Tobacco Epidemic, 2019
Alebshehy, R. (2019) · Cited by 1,331
Health at a Glance 2021: OECD Indicators
OECD (2021) · Health at a Glance · doi:10.1787/ae3016b9-en · Cited by 1,212
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
Addressing Problematic Opioid Use in OECD Countries
OECD (2019) · OECD Health Policy Studies · doi:10.1787/a18286f0-en · Cited by 778
Lozano, R., Fullman, N., Abate, D., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32281-5 · Cited by 538
Haakenstad, A., Irvine, C. M. S., Knight, M., Bintz, C., Aravkin, A. Y., Zheng, P., Gupta, V., Abrigo, M. R. M., Abushouk, A. I., Adebayo, O. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00532-3 · Cited by 434
Preventing Harmful Alcohol Use
OECD (2021) · OECD health policy studies · doi:10.1787/6e4b4ffb-en · Cited by 395
Gouglas, D., Thanh Le, T., Henderson, K., Kaloudis, A., Danielsen, T., Hammersland, N. C., Robinson, J. M., Heaton, P. M., & Røttingen, J.-A. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30346-2 · Cited by 280
A systemic resilience approach to dealing with Covid-19 and future shocks
(2020) · OECD Policy Responses to Coronavirus (COVID-19) · doi:10.1787/36a5bdfb-en · Cited by 227
Long-term care protection for older persons: A review of coverage deficits in 46 countries
Scheil-Adlung, X. (2018) · Human Rights Documents online · doi:10.1163/2210-7975_hrd-4022-2015049 · Cited by 66
Omicron is supercharging the COVID vaccine booster debate
Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-03592-2 · Cited by 53
Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine DosePreprint
Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Tanfous, T. B., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.14.480394 · Cited by 41
Amiri, A., & Solankallio-Vahteri, T. (2018) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2018.11.010 · Cited by 34
Kostova, D., Husain, M. J., Sugerman, D. E., Hong, Y., Saraiya, M., Keltz, J., & Asma, S. (2017) · Emerging infectious diseases · doi:10.3201/eid2313.170581 · Cited by 33
The cost of vaccination throughout life: A western European overview
Ethgen, O., Cornier, M., Chriv, E., & Baron‐Papillon, F. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1154649 · Cited by 23
Cited by
OECD (2023) · Government at a Glance · doi:10.1787/3d5c5d31-en · Cited by 510
Metadata
- Venue
- OECD Health Working Papers
- Published
- 2022-07-28
- ISSN
- 1815-2015 (ISSN-L)
- OpenAlex
- W4290005696
- Cited by
- 263
- References
- 16
- Type
- report
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.